Yaya An Yi Biyayyar Tsakanin Tsarin Mulki na Age?

Akwai magunguna daban-daban na macene degeneration , ko kuma abin da ake kira a matsayin maƙasudin macular degeneration (AMD) -dan yanayin da hankali ya share fitar da hangen nesa. Gaba ɗaya, waɗannan jiyya na iya hana kuma jinkirin ƙarawar hangen nesa ta hanyar hana lalacewa. Abin takaici, ba sa yawan gyara lalacewa ga macula ko farfadowa wanda ya riga ya rasa.

Dangane da irin yanayin ku, bitamin, magunguna, tiyata, da / ko hanyoyin kwantar da hankulanku za a iya la'akari.

Ƙararruwar Kwayoyi

A cewar Cibiyar Harkokin Ophthalmology ta Amirka, yawancin bitamin na iya rage jinkirin farkon AMD, wanda shine yawancin AMD.

A cikin nazarin cututtuka na Eye Age-related Eye (wani babban Cibiyar Gudanar da Harkokin Kasuwanci ta kasa-wanda ya biyo bayan kimanin mutane 3,600 da sauye-sauye na AMD), masu bincike sun gano cewa daukar matakai masu yawa na antioxidants da zinc yau da kullum sun rage hadarin samfurin AMD mai ci gaba 25 bisa dari. Shirin nazarin bitamin ya ƙunshi:

Abin da kari da kuma allurai ne daidai a gare ku, idan akwai, dole ne ƙwararren likitanku ya ƙaddara. Bi shawara da tsarin da aka ba da shawara don ku.

Magunguna

Jirgin jini a cikin idanunsa babban ɓangare ne na macular degeneration, da kuma aiki na ciwon ƙananan ciwon ƙwayar endothelial (VEGF) -a gina jiki-na iya taka rawar a cikin wannan.

An nuna alamun magungunan VEGF a tasiri don hana yaduwar karfin jini wanda zai iya lalata kuma ya haifar da lalacewa ga macula.

Anti-VEGF magunguna sun hada da:

Kowace an ba ta ta hanyar allura a cikin ido, wanda wani mai ilimin likitancin mutum yayi.

Ya kamata ku yi tsammanin karɓar maganin rigakafi na gida kafin yin allura tare da anti-VEGF. Mafi yawancin mutane suna iya jure yanayin da kyau kuma ba tare da jin zafi ko rashin jin daɗi ba.

Hanyoyin hanyoyin VEGF masu rinjaye yana wuce na kusan wata daya. Kuna iya buƙata hanyoyi maimaita idan duba ido ya nuna kullun jini yana gudana.

Dokokin Musamman

Akwai hanyoyi masu magungunan da yawa waɗanda zasu iya hana kuma rage jinkirin ci gaban macular degeneration. Kwarar ido ko likitancin ku zai bincika idanu da hangen nesa da hankali don sanin ko za ku amfana daga ko kuma ku yi haƙuri a kan wadannan hanyoyin; wannan yanke shawara abu ne mai rikitarwa.

Hanyar da aka yi amfani da shi don maye gurbin macular sun hada da:

Laser tiyata: Hanyar tiyata laser amfani da laser da aka yi niyya don hana yaduwar jini a cikin ido. Ana yin hakan a yawancin wuri, kuma tasirin ya kasance na tsawon shekaru. Wannan ya ce, za a iya sake yin hakan a wasu lokuta idan an buƙata.

Photodynamic Far: Wannan magani ne ya shafi magungunan magani wanda ke haifar da ƙananan ƙwayoyin jini a cikin idanu don ƙuntatawa don haka basu iya yin la'akari.

Ana yin amfani da haske ta hanyar haske, wanda aka yi niyya ga ƙananan jini da laser. Ya kamata ku yi tsammanin za ku farka a lokacin da ku karbi maganin da ke cikin gida domin ta'aziyya da kulawa da jin zafi. Bayan hanya, idanunku zai iya zama haske fiye da yadda ya saba, kuma za a ba ku umarnin yadda za ku kare idanunku.

Tsarin Tsarin Farawa: An yi amfani da implants na ƙwaƙwalwar ajiya da dama. Idan aka yi amfani da AMD, an saka na'urar a bayan idon ido. Aikin implant yana aiki ne ta hanyar hangen nesa mai girma da kuma aika hotuna zuwa ɓangaren sashin jiki. Ana amfani da shi, amma ba a yadu ba.

Magunguna Na Ƙarin (CAM)

Duk da yake akwai alamun shaida cewa wasu bitamin na iya hana ci gaba na AMD, akwai wasu shaidar da za su iya taimakawa wajen amfani da ganye. Ga wasu hanyoyin da za ku ji game da su. Idan waɗannan zaɓuɓɓuka suna son ku, ku yi magana da magungunan likitanku kafin ku haɗa kowane abu a cikin shirin ku.

Salon

Akwai abubuwa masu yawa na salon rayuwa wanda zai iya rage yawan haɗarin AMD na bunkasa, kuma ya kamata su zama wani ɓangare na shirin kula da AMD ɗinku duka:

> Sources:

> Aruna Gorusupudi, Kelly Nelson, da Paul S Bernstein. Abin da ke faruwa a cikin Age 2 Nazarin: Micronutrients a cikin jiyya na Macene Degeneration. Adv Nutr. 2017 Jan; 8 (1): 40-53. An buga shi a ranar 2017 Janairu 11: 10.3945 / an.116.013177

> Bahadorani S, Singer M. Ci gaba da gaba a cikin gudanarwa da fahimtar macene degeneration. 2017 Apr 20; 6: 519. Doi: 10.12688 / f1000research.10998.1. eCollection 2017, DOI: 10.12688 / f1000research.10664.1

> Evans JR. Ginkgo biloba cirewa don yawan shekarun macular degeneration. Cochrane Database Syst Rev 2013 Janairu 31; (1): CD001775. Doi: 10.1002 / 14651858.CD001775.pub2.

> Hernández-Zimbrón LF, Zamora-Alvarado R, Ochoa-De la Paz L, et al. Magancewar Maɗaukaki ta Tsarin Age: Sabon Sa'idodi don Kulawa da Gudanarwa na AMD. Oxid Med Cell Longev. 2018 Feb 1; 2018: 8374647. Doi: 10.1155 / 2018/8374647. eCollection 2018.

> Korobelnik JF, Rougier MB, Delyfer MN, et al. Hanyoyin Abincin Abinci tare da Lutein, Zeaxanthin, da kuma ω-3 a kan Macular Pigment: A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Nov 1; 135 (11): 1259-1266. Doi: 10.1001 / jamaophthalmol.2017.3398.

> Shusheng Wang da Khrishen Cunnusamy. Magungunan gargajiya na gargajiya na kasar Sin (TCM) don magance shekarun da suka shafi shekarun da suka shafi Macular-Evaluation of WO2012079419. Kwararre Ake Ther Pat. 2013 Feb; 23 (2): 269-272.Da aka buga a cikin labaran 2012 Janairu 10: 10.1517 / 13543776.2013.751972

> Wang Y, Zhao L, Lu F, et al. Hanyoyin Tsarin Halitta na Bilberry Anthocyanins ta hanyar Antioxidant, Anti-Inflammatory, da Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Abubuwan Hudu a Tsarin Ruwa Mai Fyaucewa-Tsarin Tsarin Dattijai na Tsarin Laifi a Pomeded Rabbits. Molecules. 2015 Dec 14; 20 (12): 22395-410. Doi: 10.3390 / kwayoyin201219785.

Bayani: Bayanan da aka ƙunshe a wannan shafin an yi nufi don dalilai na ilimi kawai kuma ba a maimakon shawara, ganewar asali ko magani ta likita mai lasisi. Ba'a nufin ɗaukar dukkan kariya, hulɗar miyagun ƙwayoyi, yanayi ko cutarwa. Ya kamata ku nemi kulawa da lafiya ga duk wani al'amura na kiwon lafiya ku tuntuɓi likitan ku kafin kuyi amfani da magani ko yin canji ga tsarinku.